*** This page is archived and provided for reference purposes only ***

Skip Over Navigation Links

NIH Research Matters

December 2008 Archive

December 15, 2008

Photo of multiple vitamin pills and spoon.

Dietary Supplements Fail to Prevent Prostate Cancer

Two large-scale clinical trials found that regular intake of vitamin E, vitamin C or selenium does not reduce the risk of prostate cancer or other cancers in older men, as some previous studies had suggested.

Three-dimensional image of lumpy round cell with multiple extensions.

Compound Helps Detect Cancer Cells in Mice

Researchers have developed an imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs of mice. Similar compounds may one day help doctors monitor their patient's tumors and even aid in tumor removal.

Scanning electron micrograph showing long cell at center among more disc-shaped cells.

New Genetic Target for Sickle Cell Disease Therapy

Researchers have identified a gene involved in the inherited blood disorders sickle cell disease and thalassemia. The discovery identifies a potential new target for therapies that could dramatically alter the course of the disorders.

December 8, 2008

Photo of scientist examining computer monitor

Gene Activity Can Predict Survival Rates of Patients with Lymphoma

A new study shows that gene activity can be used to predict survival rates of people with a type of non-Hodgkin's lymphoma called diffuse large B-cell lymphoma (DLBCL). The method can potentially be used to guide treatment and to help develop future therapies.

Electron micrograph showing cluster of many bacteria.

Gut Microbiomes Differ Between Obese and Lean People

A new study has found that obese and lean twins have clear differences in their gut microbial communities. The finding points the way for future research into the roles that gut microbes may play in obesity and other health conditions.

Electron micrograph of tuberculosis bacteria

Experimental Drug Destroys TB Bacteria From Within

Scientists have discovered how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis (TB). The finding could help scientists develop new approaches for combating dormant TB infections, which are especially difficult to treat. The research may ultimately lead to improved drugs against other bacteria as well.

Contact Us

E-mail: nihresearchmatters@od.nih.gov

Mailing Address:
NIH Research Matters
Bldg. 31, Rm. 5B64A, MSC 2094
Bethesda, MD 20892-2094

About NIH Research Matters

Editor: Harrison Wein, Ph.D.
Assistant Editors: Vicki Contie, Carol Torgan, Ph.D.

NIH Research Matters is a weekly update of NIH research highlights from the Office of Communications and Public Liaison, Office of the Director, National Institutes of Health.

ISSN 2375-9593

This page last reviewed on December 3, 2012

Social Media Links